NPPA and Huntington disease: In a prospective single‐site controlled cohort study with standardized collection of CSF, blood, and phenotypic and imaging data, performed among 80 participants (20 healthy controls, 20 pre‐manifest HD, and 40 manifest HD), the KP metabolites in CSF and plasma were stable over 6 weeks of observation.140